Here are four insights:
1. The attorney general’s office questions whether payers are limiting coverage for those patients who are very sick.
2. The office also wants to know how payers authorize the use of hepatitis C drugs.
3. The office sent subpoenas to payers including Aetna, CareConnect and EmblemHealth.
4. Because of hepatitis C’s escalated cost, payers are conflicted whether they should prioritize medication access to patients who have progressed further with the disease.
More articles on coding, billing & collections:
Oscar suffers $105M financial losses on ACA exchanges — 5 key points
Florida House approves free-market healthcare reform proposals — 8 key points
President Obama to speak in Milwaukee about ACA’s impact: 6 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
